Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies

Ravgen is a biotech company engages in research of the prenatal diagnostic field and development of non-invasive prenatal diagnostic testing. Read more

14 Followers on Owler
14 Followers on Owler
14 Followers on Owler
14 Followers on Owler

Ravgen is a biotech company engages in research of the prenatal diagnostic field and development of non-invasive prenatal diagnostic testing. Read more

Ravinder Dhallan's photo - Chairman & CEO of Ravgen

Chairman & CEO

Ravinder Dhallan

CEO Approval Rating

70/100

Founded:

06/2000

Status:

PrivateIndependent Company

SIC Code:

8000 NAICS listing »

Est. Annual Revenue
Est. Employees
Sector

Update Industry
Headquarters

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Ravgen's top 3 competitors are Natera, Ambry Genetics and 23andMe. Together they have raised over 1.4B between their estimated 2.3K employees. Ravgen's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 216.4M. Ravgen has 33 employees and is ranked 4th among it's top 10 competitors. The top 10 competitors average 577.

Natera is perceived as one of Ravgen's biggest rivals. Natera was founded in 2004 in San Carlos, California. Natera is in the Biotechnology field. Natera generates $355.3M more revenue than Ravgen.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 33 a good estimate for Ravgen's Employee count?

I don't know

Trending News for Ravgen and Ravgen's Competitors

January 25, 2021

CompanyNews HQ

Roche's faricimab meets primary endpoint in two global phase III studies and shows potential to extend time between treatments up to 16 weeks for people with neovascular age-related macular degeneration

Faricimab given at intervals of up to every 16 weeks demonstrated non-inferior visual acuity gains co... See more »

January 25, 2021

CompanyNews HQ

Roche renews partnership with Sysmex to deliver haematology testing solutions

This successful long-running partnership continues to evolve and bring haematology testing innovation... See more »

January 25, 2021

PharmaLive

Roche's Macular Degeneration Drug Hits Mark in Two Phase III Trials

Roche announced topline data from two identical Phase III trials (TENAYA and LUCERNE) of faricimab in... See more »

Acquisitions

No recent acquisitions found related to Ravgen

Ravgen Funding History

No recent funding data found related to Ravgen

Investments

No recent investments found related to Ravgen

Social Media

Headquarters

9241 Rumsey Rd

Columbia, Maryland21045

(410) 715-2111

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Ravgen is a biotech company engages in research of the prenatal diagnostic field and development of non-invasive prenatal diagnostic testing. Ravgen was founded in 06/2000. Ravgen's headquarters is located in Columbia, Maryland, USA 21045. Ravgen's C...

CEO

Ravgen's Chairman & CEO, Ravinder Dhallan, currently has an approval rating of 70%. Ravgen's primary competitors are Natera, Ambry Genetics & 23andMe.

Website

ravgen.com

Frequently Asked Questions about Ravgen

  1. When was Ravgen founded?

    Ravgen was founded in 06/2000

  2. Who is Ravgen's CEO?

    Ravgen's CEO is Ravinder Dhallan

  3. How much revenue does Ravgen generate?

    Ravgen generates $6.6M in revenue

  4. How much funding does Ravgen have?

    Ravgen has historically raised $0 in funding

  1. Where is Ravgen's headquarters?

    Ravgen's headquarters is in Columbia Maryland, USA

  2. How many employees does Ravgen have?

    Ravgen has 33 employees

  3. Who are Ravgen's competitors?

    Ravgen's top competitors are Natera, Ambry Genetics, 23andMe
Stay up-to-date with the latest news on Ravgen

© 2021 Owler, Inc.